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Rapid, metal-free and aqueous synthesis of
imidazo[1,2-a]pyridine under ambient conditions†
Michael R. Chapman, Maria H. T. Kwan, Georgina E. King, Benjamin A. Kyﬃn,
A. John Blacker, Charlotte E. Willans* and Bao N. Nguyen*
A novel, rapid and eﬃcient route to imidazo[1,2-a]pyridines under
ambient, aqueous and metal-free conditions is reported. The
NaOH-promoted cycloisomerisations of N-propargylpyridiniums
give quantitative yield in a few minutes (10 g scale). A comparison
of common green metrics to current routes showed clear improve-
ments, with at least a one order of magnitude increase in space-
time-yield.
The imidazo[1,2-a]pyridine scaﬀold, found at the core of many
pharmaceutical drugs such as zolimidine (peptic ulcer),1 zolpi-
dem (insomnia and brain disorders)2 and rifaximin (hepatic
encephalopathy),3,4 is one of the most privileged nitrogen-
containing heterocycles in drug design.5–8 Industrial routes to
imidazo[1,2-a]pyridines have often been via condensations
between 2-aminopyridines and α-bromoketones/α-chloro-
ketones (Scheme 1),9,10 with an aryl or a carboxylate group at
the β position for subsequent reduction to an OH group and
derivatisation.11–13 Recent synthetic methods have focused on
functionalisation of the core scaﬀold through metal catalysed
coupling reactions (e.g. Cu,13–15 Fe,16 Au,7 Ru,18 and
Pd19,20),14,15 with attendant problems of product separation,
and catalytic routes to assemble the scaﬀold.16,17 Furthermore,
most of these processes employ undesirable solvents such as
N,N-dimethylformamide,18–21 1,2-dichloroethane,22 1,4-
dioxane,23,24 or acetonitrile,25,26 relatively high temperature,
high catalyst loading and long reaction time.16
Bakherad and co-workers reported a Sonogashira-cyclisa-
tion cascade reaction catalysed by Pd catalysts.27,28 This reac-
tion has been applied by Marugan et al. to generate a wide
range of imidazopyridinium analogues as antagonists of
neuropeptide S receptor.29 Further functionalisations at the
methyl position (R2 in Scheme 1) are also well established.30–34
We were particularly interested in the cyclisation step, which
was proposed to be catalysed by the Pd catalyst. We hypoth-
esised that the same cyclisation could be achieved through a
base-catalysed rearrangement of the propargyl fragment to an
allenic group35–41 and subsequent Nazarov cyclisation.42–44
This led to a remarkably rapid, mild, general and high yielding
NaOH-promoted heterocyclisation approach to imidazo[1,2-a]
pyridines via pyridinium bromide precursors under ambient
and aqueous conditions, which we are reporting here
(Scheme 1).
N-Propargylic pyridinium bromide 1a, which was prepared
by reaction of the corresponding 2-aminopyridine with propar-
gyl bromide, was added to an aqueous solution of NaOH
(1 equivalent) with vigorous stirring under ambient con-
ditions. A suspension of a pale yellow oil was immediately
evident which was subsequently extracted into ethyl acetate,
concentrated and identified as spectroscopically pure imidazo
[1,2-a]pyridine, 2a, isolated in quantitative yield (Table 1, entry
1). Methanol and ethanol performed almost equally well as
Scheme 1 Synthetic methods to assemble imidazo[1,2-a]pyridines.
†Electronic supplementary information (ESI) available. CCDC 1471645,
1471647–1471650 and 1471653–1471656. For ESI and crystallographic data in
CIF or other electronic format see DOI: 10.1039/c6gc01601d
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solvent compared to water (entries 3 and 4), giving the desired
product in high yield. The reaction in water, however, enabled
a very simple workup either with an ethyl acetate extraction or
simple phase separation at larger scales (vide infra). Employing
KOH or DABCO instead of NaOH in water provided the
product in quantitative yield (entries 5 and 6). Interestingly,
using DABCO as the base in anhydrous DMSO gave no conver-
sion (entry 13). Addition of catalytic amount of water led to
some conversion (entry 14), but at much lower rate than that
of the same reaction in water. A proton source is therefore
essential to the reaction. Weaker bases such as Na2CO3,
Cs2CO3 and K2CO3 proved less soluble, requiring slightly elev-
ated temperatures and longer reaction times to achieve com-
parable yields (entries 7–9). Other organic bases, i.e. NEt3 and
(iPr)2EtN, led to biphasic reaction mixtures and low yield of
the desired product (entries 10 and 11, respectively), despite
similar basicity to DABCO in DMSO.45
To rule out the possibility of a reaction catalysed by trace
amount of metal, ultra-high purity NaOH was employed as
base (entry 2). The same quantitative yield and reaction time
was obtained as with NaOH of standard purity, confirming the
metal-free nature of the reaction. Reducing the amount of
NaOH to 0.2 eq., however, resulted in only fractional conver-
sion of the starting material (entry 12). Reaction conditions
using NaOH as the least expensive and most readily available
base, were taken forward for the rest of the study.
The substrate scope of the reaction was subsequently
explored (Scheme 2, 2b–i). Near-quantitative isolated yields
were obtained from substrates 1b–i containing electron donat-
ing and electron withdrawing substituents. Analytically pure
(NMR and microanalysis) imidazopyridines 2b–i were obtained
in all cases after a simple extraction. Importantly, the method
is tolerant of methyl, chloro, bromo, iodo, trifluoromethyl,
nitro and amino-substituents. X-ray crystallographic analysis
of 2e, 2g and 2i confirmed their solid-state structures and the
positions of substituents on the imidazopyridines (see ESI†).
This synthetic method represent a significant advantage over
current metal-catalysed routes to imidazo[1,2-a]pyridines as
halogens, which are required for subsequent functionalisation,
and are well tolerated without compromise in yield and
selectivity.
Disubstituted internal alkyne 2-amino-1-(2-butynyl)pyridi-
nium bromide 1j, however, gave no conversion under standard
conditions. This was attributed to a decrease in the acidity of
the propargyl CH2, which is crucial for isomerisation to the
corresponding allene. When tBuOK in tBuOH was employed,
nearly quantitative conversion of 1j to product 2j was observed.
Further functionalisation of the resulting imidazopyridines 2a,
2b, 2e, 2g and 2i by treatment with benzyl bromide, methyl
iodide and allyl bromide led to isolation of imidazopyridi-
niums 3ak, 3bl, 3gl, 3im, and 3ik in good to excellent yield
(Scheme 4).
The mechanism of the reaction was probed in a deuterium
labelling experiment. Cyclisation of 4 methyl substituted pyri-
dinium bromide 1b to 2b upon treatment with 1 eq. of NaOH
was performed in D2O and the deuterium incorporation evalu-
ated by 1H NMR spectroscopy. Only one methyl signal was
observed in the 1H NMR spectrum of the product. The new
Table 1 Optimisation of reaction conditions
Entry Base Solvent T (°C) Time (min) Yielda,b (%)
1 NaOH H2O r.t. 2 >99
2c NaOH H2O r.t. 2 >99
3 NaOH MeOH r.t. 5 95
4 NaOH EtOH r.t. 5 95
5 KOH H2O r.t. 2 >99
6 DABCO H2O r.t. 2 >99
7 Na2CO3 H2O 40 20 94
8 K2CO3 H2O 40 5 90
9 Cs2CO3 H2O r.t. 5 93
10 NEt3 H2O r.t. 30 48
11 iPr2EtN H2O r.t. 30 30
12d NaOH H2O r.t. 10 18
13e DABCO DMSO r.t. 2 0
14 f DABCO DMSO r.t 2 15
a Reaction conditions: pyridinium bromide (0.5 mmol), base
(0.5 mmol), solvent (5 mL). b Isolated yield. c Extra pure NaOH assay:
≥99.9995% metals basis. dOnly 0.2 equivalent of NaOH was employed.
eUsing anhydrous d6-DMSO.
fUsing anhydrous d6-DMSO and 20 mol%
of H2O, giving 66% conversion after 24 hours. Scheme 2 Scope of substrates for aqueous cyclisation of 2-amino-1-
propargylpyridiniums 1b–j to product 2b–j. Reaction performed on
1.0 mmol scale in 10 mL of water.
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methyl group, formed at the terminal alkyne position of the
substrate, was fully deuterated. An exchange experiment of the
non-deuterated product 2b with D2O in the presence of NaOH
showed no exchange with deuterium at the same methyl
group.
Based on the experimental evidence above, a plausible
mechanism is proposed in Scheme 3. It starts with a base-
induced alkyne–allene isomerisation.35–41 This process nor-
mally requires a stronger base, e.g. KOtBu, BuLi, but the pres-
ence of the pyridinium next to the propargyl CH2 makes it
significantly more acidic and enables the use of NaOH. Sub-
sequent cyclisation in a Nazarov-type mechanism and tauto-
merisation leads to the product with a fully deuterated methyl
group in D2O. The base plays a dual role as catalyst for the iso-
merisation to allene and as a reagent to remove the byproduct
DBr.
The remarkably facile and very rapid nature of the reaction
led us to explore the scalability of this novel route to imidazo-
pyridines. Substrate 1a was added over 5 minutes to a vigor-
ously stirred aqueous solution of NaOH using a powder
addition funnel on a 47 mmol (10.0 g) scale (Fig. 1). The
product was easily separated at the end of the addition, giving
the product 2a in the same quantitative yield and high purity.
The green metrics for this process were calculated and are
summarised in Table 2. These are compared with similar
metrics from two industrial syntheses, one on lab scale and
one optimised on kilogram scale.9,46 Atom Economy (AE),50
reaction mass eﬃciency (RME)49 and process mass intensity
(PMI)49,51 are three of the currently preferred measures for
evaluation of process sustainability.52 These metrics for our
Scheme 4 Scope of substrates for functionalisation of imidazo[1,2-a]
pyridines. Reaction conditions: imidazo[1,2-a]pyridine (1.5 mmol), R2-X
2.0–2.6 eq., MeCN (30 mL).
Scheme 3 Proposed mechanism for the cyclisation based on deuter-
ium labelling results.
Fig. 1 A scaled up reaction setup. (a) before reaction; (b) during
addition of 1a (zoomed in); (c) phase separation at the end of the reac-
tion (zoomed in).
Table 2 Green metrics comparison between the scaled-up process
and the current industrial route to close analogues9,46
Metrics
This work
(2a, 10 g
scale)a
Current route
1 (4a, 2.8 g
scale)47
Current
route 2 (4b,
3 kg scale)9
Atom economy (%) 52 36 51
E-factor without water
(g waste/g product)47,48
40.1 41.9 12.0
E-factor with water
(g waste/g product)
51.5 77.6 22.8
Eﬀective mass yieldb (%) 39 7.2 27
Reaction mass
eﬃciencyc (%)
72 and 51 7.2 27
Process mass intensity
(material/product)d
42.7 45.1 19.4
Space-time-yielde
(g L−1 min−1)
0.42 and 10.9 0.03 0.059
a Calculated as combined alkylation and cyclisation stages or shown
separately. bNaOH, NaHCO3 and CaCO3 were estimated based on
assumed stoichiometries. c Curzons’ method of calculating reaction
mass eﬃciency was used, ignoring water.49 d This measure includes
solvents but not water. e Space-time-yields exclude work-up time which
are not optimised and can be variable.
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reported process are consistently superior to those of the
established route using α-halogencarbonyl reagents for
5-fluoro and 5-bromo imidazo[1,2-a]pyridine-2-carbaldehyde,
albeit without one functional group in the product.9,46 It is
worth noting that the latter has been operated at kilogram
scale with optimised work-up to improve E-factor and PMI
through reduction of solvent use. The eﬀective mass yield
(EMY)53 shows higher eﬃciency for the new route, even com-
pared to the optimised current process, although this metric
requires definition of benign substances which can be conten-
tious. Importantly the space-time-yield (STY) in the alkylation
step is 7–14 times higher, and the STY in the cyclisation step
is 185–363 times higher, than the comparative processes. In
addition, the solvents in our process, i.e. iPrOH, EtOAc and
water, are all ‘recommended’ solvents, while the main solvent
in the current processes, 1,2-dimethoxyethane, is considered
‘hazardous’.52 Finally, the much faster reactions reported here
mean that a telescoped process can potentially be carried out
with acceptable solvents, heating and cooling.
In conclusion, we report a novel and green route to imidazo-
[1,2-a]pyridines which involves no metal catalyst and is extre-
mely fast when performed in water. This route benefits from
highly competitive green metrics and 1–2 magnitude higher
STY compared to current synthetic processes. Investigation to
expand the substrate scope and to understand the eﬀect of
water in this reaction is in progress and will be disseminated
in the near future.
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